硬化症-话题@MedSci

#硬化症#

413篇内容 | 2650人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1983065, encodeId=0d71198306517, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=显著改善认知能力，诺华公布多发性硬化症新药全新数据分析, objectType=article, longId=166061, objectId=e9c816606197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9c816606197, replyNumber=0, likeNumber=68, createdTime=2020-02-24, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9c816606197, moduleTitle=显著改善认知能力，诺华公布多发性硬化症新药全新数据分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9c816606197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983071, encodeId=228d19830e1ed, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Ponesimod治疗复发性多发性硬化症的III期研究结果：符合其主要和次要终点, objectType=article, longId=176219, objectId=d8491e621960, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8491e621960, replyNumber=0, likeNumber=66, createdTime=2020-02-01, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8491e621960, moduleTitle=Ponesimod治疗复发性多发性硬化症的III期研究结果：符合其主要和次要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8491e621960)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983083, encodeId=b0de1983083d2, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=特发性肠系膜硬化症患者一例, objectType=article, longId=181955, objectId=78201819555f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78201819555f, replyNumber=0, likeNumber=67, createdTime=2020-09-07, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78201819555f, moduleTitle=特发性肠系膜硬化症患者一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78201819555f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983075, encodeId=ce0019830e5d0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=结节性硬化症相关癫痫外科治疗中国专家共识, objectType=article, longId=177602, objectId=11c61e7602ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11c61e7602ba, replyNumber=0, likeNumber=14, createdTime=2019-11-18, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11c61e7602ba, moduleTitle=结节性硬化症相关癫痫外科治疗中国专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11c61e7602ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983081, encodeId=1b8d198308130, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Sci Rep：与结节性硬化症和依维莫司治疗结果相关的肾血管平滑肌脂肪瘤变异分析, objectType=article, longId=181658, objectId=083418165848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=083418165848, replyNumber=0, likeNumber=75, createdTime=2019-11-02, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=083418165848, moduleTitle=Sci Rep：与结节性硬化症和依维莫司治疗结果相关的肾血管平滑肌脂肪瘤变异分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=083418165848)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983059, encodeId=ebd11983059a2, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, objectType=article, longId=164344, objectId=ad231643441f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad231643441f, replyNumber=0, likeNumber=70, createdTime=2019-05-29, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad231643441f, moduleTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad231643441f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983052, encodeId=b3ff19830524a, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=结节性硬化症并血管瘤1 例, objectType=article, longId=163197, objectId=d00916319e36, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00916319e36, replyNumber=0, likeNumber=61, createdTime=2019-04-26, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00916319e36, moduleTitle=结节性硬化症并血管瘤1 例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00916319e36)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983054, encodeId=3919198305439, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=FDA批准Merck的Mavenclad（克拉屈滨）用于治疗多发性硬化症, objectType=article, longId=163429, objectId=01811634295d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01811634295d, replyNumber=0, likeNumber=0, createdTime=2019-09-26, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01811634295d, moduleTitle=FDA批准Merck的Mavenclad（克拉屈滨）用于治疗多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01811634295d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983084, encodeId=4792198308409, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=英国NICE更新指南，推荐将拜尔的大麻二酚药物Sativex用于治疗多发性硬化症患者的痉挛, objectType=article, longId=183118, objectId=b4f118311887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f118311887, replyNumber=0, likeNumber=0, createdTime=2020-05-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f118311887, moduleTitle=英国NICE更新指南，推荐将拜尔的大麻二酚药物Sativex用于治疗多发性硬化症患者的痉挛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f118311887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983072, encodeId=402f19830e22b, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞, objectType=article, longId=176318, objectId=a36e1e6318f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a36e1e6318f6, replyNumber=0, likeNumber=86, createdTime=2020-06-25, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a36e1e6318f6, moduleTitle=J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a36e1e6318f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983094, encodeId=49d119830941c, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Sci Rep：系统性硬化症胃黏膜凋亡和增殖因子的表达与疾病类型有关, objectType=article, longId=184522, objectId=bedc18452296, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bedc18452296, replyNumber=0, likeNumber=87, createdTime=2020-10-27, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bedc18452296, moduleTitle=Sci Rep：系统性硬化症胃黏膜凋亡和增殖因子的表达与疾病类型有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bedc18452296)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983069, encodeId=4df61983069f0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Rheumatol：系统性硬化症患者缺血性卒中的风险升高, objectType=article, longId=172156, objectId=8dc01e2156a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dc01e2156a9, replyNumber=0, likeNumber=67, createdTime=2020-04-29, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dc01e2156a9, moduleTitle=J Rheumatol：系统性硬化症患者缺血性卒中的风险升高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dc01e2156a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983058, encodeId=2d98198305849, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Ear Nose Throat J：耳硬化症引起的永久性听力损失镫骨外科手术治疗研究, objectType=article, longId=164040, objectId=a9191640402a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9191640402a, replyNumber=0, likeNumber=79, createdTime=2019-05-19, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9191640402a, moduleTitle=Ear Nose Throat J：耳硬化症引起的永久性听力损失镫骨外科手术治疗研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9191640402a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983055, encodeId=02c7198305502, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Gastroenterology：系统性硬化症患者食管动力异常与皮肤或肺部受累的关系, objectType=article, longId=163742, objectId=4f59163e4260, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f59163e4260, replyNumber=0, likeNumber=57, createdTime=2019-08-08, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f59163e4260, moduleTitle=J Gastroenterology：系统性硬化症患者食管动力异常与皮肤或肺部受累的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f59163e4260)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983089, encodeId=6f4919830899d, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降, objectType=article, longId=183715, objectId=fe2f183e1514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2f183e1514, replyNumber=0, likeNumber=60, createdTime=2019-12-26, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2f183e1514, moduleTitle=加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2f183e1514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983047, encodeId=8f59198304e3f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Alkermes和Biogen宣布美国FDA接受了Diroximel富马酸盐治疗多发性硬化症的新药申请 , objectType=article, longId=161249, objectId=55e816124925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55e816124925, replyNumber=0, likeNumber=63, createdTime=2019-06-18, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55e816124925, moduleTitle=Alkermes和Biogen宣布美国FDA接受了Diroximel富马酸盐治疗多发性硬化症的新药申请 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55e816124925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983095, encodeId=fd3e19830957d, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=2019 专家建议：结节性硬化症, objectType=article, longId=184861, objectId=0f1d1848614d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f1d1848614d, replyNumber=0, likeNumber=15, createdTime=2020-04-12, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f1d1848614d, moduleTitle=2019 专家建议：结节性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f1d1848614d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983051, encodeId=a4eb1983051b8, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Ann Rheum Dis：弥漫性皮肤系统性硬化症患者的进行性皮肤纤维化与肺功能下降和生存率降低有关, objectType=article, longId=162116, objectId=82c516211694, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82c516211694, replyNumber=0, likeNumber=70, createdTime=2019-10-25, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82c516211694, moduleTitle=Ann Rheum Dis：弥漫性皮肤系统性硬化症患者的进行性皮肤纤维化与肺功能下降和生存率降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82c516211694)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983086, encodeId=e9341983086ce, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=CLIN CHEM LAB MED：三种分析方法比较肌萎缩性侧索硬化症、额颞叶痴呆和对照组中血清和CSF pNfH水平的相关性, objectType=article, longId=183132, objectId=b63618313274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b63618313274, replyNumber=0, likeNumber=63, createdTime=2020-06-20, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b63618313274, moduleTitle=CLIN CHEM LAB MED：三种分析方法比较肌萎缩性侧索硬化症、额颞叶痴呆和对照组中血清和CSF pNfH水平的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b63618313274)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983073, encodeId=d75f19830e363, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Clinica Chimica Acta：中国汉族系统性硬化症人群自身抗体商业免疫试剂的评价, objectType=article, longId=177025, objectId=6d051e7025ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d051e7025ac, replyNumber=0, likeNumber=68, createdTime=2019-10-25, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d051e7025ac, moduleTitle=Clinica Chimica Acta：中国汉族系统性硬化症人群自身抗体商业免疫试剂的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d051e7025ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

硬化症

2020-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

显著改善认知能力，诺华公布多发性硬化症新药全新数据分析

2020-02-24

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Ponesimod治疗复发性多发性硬化症的III期研究结果：符合其主要和次要终点

2020-02-01

30397604 (审核中...)

前往app查看评论内容

#硬化症#

特发性肠系膜硬化症患者一例

2020-09-07

30397604 (审核中...)

前往app查看评论内容

#硬化症#

结节性硬化症相关癫痫外科治疗中国专家共识

2019-11-18

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Sci Rep：与结节性硬化症和依维莫司治疗结果相关的肾血管平滑肌脂肪瘤变异分析

2019-11-02

30397604 (审核中...)

前往app查看评论内容

#硬化症#

由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用

2019-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

结节性硬化症并血管瘤1 例

2019-04-26

30397604 (审核中...)

前往app查看评论内容

#硬化症#

FDA批准Merck的Mavenclad（克拉屈滨）用于治疗多发性硬化症

2019-09-26

30397604 (审核中...)

前往app查看评论内容

#硬化症#

英国NICE更新指南，推荐将拜尔的大麻二酚药物Sativex用于治疗多发性硬化症患者的痉挛

2020-05-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞

2020-06-25

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Sci Rep：系统性硬化症胃黏膜凋亡和增殖因子的表达与疾病类型有关

2020-10-27

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Rheumatol：系统性硬化症患者缺血性卒中的风险升高

2020-04-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Ear Nose Throat J：耳硬化症引起的永久性听力损失镫骨外科手术治疗研究

2019-05-19

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Gastroenterology：系统性硬化症患者食管动力异常与皮肤或肺部受累的关系

2019-08-08

30397604 (审核中...)

前往app查看评论内容

#硬化症#

加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降

2019-12-26

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Alkermes和Biogen宣布美国FDA接受了Diroximel富马酸盐治疗多发性硬化症的新药申请 

2019-06-18

30397604 (审核中...)

前往app查看评论内容

#硬化症#

2019 专家建议：结节性硬化症

2020-04-12

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Ann Rheum Dis：弥漫性皮肤系统性硬化症患者的进行性皮肤纤维化与肺功能下降和生存率降低有关

2019-10-25

30397604 (审核中...)

前往app查看评论内容

#硬化症#

CLIN CHEM LAB MED：三种分析方法比较肌萎缩性侧索硬化症、额颞叶痴呆和对照组中血清和CSF pNfH水平的相关性

2020-06-20

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Clinica Chimica Acta：中国汉族系统性硬化症人群自身抗体商业免疫试剂的评价

2019-10-25

科室
- - 订阅+
  - 更多科室
工具
服务